List of insiders holdings for Ultragenyx Pharmaceutical Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| KAKKIS EMIL D President & CEO | 2024-09-05 11:53:36 | 564,597 2,223,985 | 2,788,582 | Form 4 |
| FMR LLC See Remark 1. | 2020-02-07 11:32:16 | 1,824,565 0 | 1,824,565 | Form 13G |
| TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G Former 10% Owner (2)(3)(4)(5) | 2015-02-13 12:24:24 | 1,596,420 0 | 1,596,420 | Form 13G |
| Kassberg Thomas Richard CBO & EVP | 2024-03-12 13:41:05 | 252,823 0 | 252,823 | Form 4 |
| Aliski William Director | 2021-06-28 18:26:31 | 70,974 80,806 | 151,780 | Form 4 |
| Pinion John Richard See Remarks | 2024-03-05 20:15:48 | 120,668 0 | 120,668 | Form 4 |
| Huang Dennis Karl See Remarks | 2024-03-05 20:17:17 | 114,402 0 | 114,402 | Form 4 |
| Harris Erik EVP & Chief Commercial Officer | 2024-03-05 20:08:18 | 101,363 0 | 101,363 | Form 4 |
| Sharp Shalini EVP, Finance | 2020-10-16 19:15:35 | 97,812 0 | 97,812 | Form 4 |
| Horn Howard Chief Financial Officer | 2024-10-11 16:48:48 | 92,301 0 | 92,301 | Form 4 |
| Dier Mardi CFO & Executive Vice President | 2022-10-17 18:49:56 | 66,695 0 | 66,695 | Form 4 |
| Parschauer Karah Herdman EVP and Chief Legal Officer | 2024-06-12 19:47:14 | 57,981 0 | 57,981 | Form 4 |
| Crombez Eric EVP and Chief Medical Officer | 2024-05-03 15:23:35 | 48,431 0 | 48,431 | Form 4 |
| Bedrosian Camille L EVP and Chief Medical Officer | 2023-03-03 20:00:36 | 46,720 0 | 46,720 | Form 4 |
| Huizenga Theodore Alan SVP, Chief Accounting Officer | 2024-09-18 13:03:31 | 42,251 0 | 42,251 | Form 4 |
| NARACHI MICHAEL Director | 2024-06-20 14:24:21 | 36,850 0 | 36,850 | Form 4 |
| WELCH DANIEL G Director | 2024-06-20 14:25:14 | 36,850 0 | 36,850 | Form 4 |
| Dunsire Deborah Director | 2024-06-20 14:29:35 | 34,975 0 | 34,975 | Form 4 |
| Fust Matthew K Director | 2024-06-20 14:26:43 | 30,105 0 | 30,105 | Form 4 |
| SULIMAN SHEHNAAZ Director | 2024-06-20 14:22:04 | 30,100 0 | 30,100 | Form 4 |
| Ray Amrit Director | 2024-06-20 14:23:42 | 27,525 0 | 27,525 | Form 4 |
| Ekman Lars Director | 2022-06-28 13:53:43 | 23,990 0 | 23,990 | Form 4 |
| Dallas Jayson Donald Alexander EVP & Chief Commercial Officer | 2018-06-04 16:50:14 | 23,830 0 | 23,830 | Form 4 |
| Hogenhuis Wladimir Chief Operating Officer | 2019-10-07 19:40:08 | 18,703 0 | 18,703 | Form 4 |
| Steen Marten Director | 2014-02-03 20:30:09 | 17,500 0 | 17,500 | Form 4 |
| Sanders Corazon (Corsee) D. Director | 2024-07-03 14:07:33 | 12,009 0 | 12,009 | Form 4 |
| AGARWAL SUNIL Chief Medical Officer | 2016-08-23 17:52:15 | 9,136 0 | 9,136 | Form 4 |
| Nadav Eran Director | 2014-07-17 16:15:52 | 7,500 0 | 7,500 | Form 4 |
| SIEGALL CLAY B Director | 2020-08-11 12:21:29 | 4,146 0 | 4,146 | Form 4 |